MedPath

Washington Cancer Institute Hematology-Oncology Associates, P.C.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19

Phase 2
Completed
Conditions
COVID-19
Interventions
Drug: Placebo
First Posted Date
2021-12-20
Last Posted Date
2022-11-23
Lead Sponsor
MedStar Health
Target Recruit Count
43
Registration Number
NCT05164120
Locations
🇺🇸

MedStar Franklin Square, Baltimore, Maryland, United States

🇺🇸

MedStar Washington Hospital Center, Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath